April 29 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc VRX.TO
* J. Michael Pearson (LON:PSON) 2015 total compensation of $143.1
million versus $10.4 million in 2014
* Says CFO Robert L. Rosiello FY 2015 total compensation
$60.4 million - SEC filing
* Group chairman Ari Kellen's FY 2015 total compensation was
$4.7 million versus $50.64 million
* Group chairman Ari Kellen's FY 2014 total compensation
includes $43.1 million of stock awards
* Howard Schiller's total 2015 compensation $606,805 versus
$27.1 million in 2014
* Valeant Pharmaceuticals says Pearson 2015 total
compensation includes $140.3 million of stock awards
* Howard Schiller's total 2014 compensation includes $23.7
million of stock awards
* Valeant Pharmaceuticals says Pearson 2015 total
compensation of $143.1 million includes $2 million of non equity
incentive plan compensation
Source - http://1.usa.gov/1Ta1a4e
Further company coverage: VRX.TO
(Bengaluru Newsroom; +1 646 223 8780)